At the forefront of medical innovation, we proudly introduce VIGIL – a groundbreaking wearable cap that delivers Transcranial Magnetic Stimulation (TMS) therapy, redefining treatment for conditions like treatment-resistant depression, stroke rehabilitation, neurodegenerative disorders, and more.

VIGIL represents a shift from traditional, clinic-bound therapy to a portable, discreet, and patient-empowered solution. With built-in programmable TMS sessions, VIGIL makes high-quality brain stimulation therapy more accessible, reducing hospital visits and enhancing long-term outcomes.

Backed by collaboration between medical professionals and leading universities like Huddersfield and Leeds, VIGIL’s mission is to expand access to life-changing therapy while reducing healthcare resource strain. From concept to clinical application, our team is dedicated to delivering personalized neurotherapeutics that support recovery, restore independence, and improve quality of life.

Join us in embracing the future of mental and neurological health care – empowered, effective, and wearable.